Refine by
Radioisotope Articles & Analysis
12 news found
These unique formulations combine targeting ligands with radioisotopes, providing dual functionalities of imaging and therapeutic action. ...
BOC Sciences provides global customers with a range of high-quality stable isotope labeling compounds for biomedical research. It recently announced the availability of labeled carbohydrates, arousing an enthusiastic response from the market. Based on extensive experience and advanced technologies, BOC Sciences has been working with partners to design and manufacture labeled carbohydrates ...
ITM-31 is a carbonic anhydrase XII (CA XII)-specific antibody Fab fragment developed by Helmholtz Munich and coupled with ITM's medical radioisotope, non-carrier-added Lutetium-177 (n.c.a. 177Lu, EndolucinBeta®). ...
Cesium-131 has the shortest half-life and highest energy level of the radioisotopes that ABS currently recommends for LDR brachytherapy for the treatment of prostate cancer. ...
C4 Imaging LLC is pleased to announce that Isoray Medical, Inc. (NYSE American: ISR) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of C4 Imaging’s Sirius positive-signal MRI (Magnetic Resonance Imaging) Markers with Isoray’s Cesium-131, brachytherapy seeds. Sirius is implanted during the treatment of prostate cancer with brachytherapy and is used ...
C4 Imaging LLC is pleased to announce that Isoray Medical, Inc. (NYSE American: ISR) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of C4 Imaging’s Sirius positive-signal MRI (Magnetic Resonance Imaging) Markers with Isoray’s Cesium-131, brachytherapy seeds. Sirius is implanted during the treatment of prostate cancer with brachytherapy and is used ...
TAE Life Sciences (TLS), a biologically-targeted radiation therapy company developing a breakthrough, accelerator-based boron neutron capture therapy (BNCT) system, today announced that it has entered into an agreement with National Center of Oncological Hadrontherapy (CNAO) to provide its Alphabeam™ Neutron System for the treatment of invasive, recurrent and difficult to treat cancers. ...
ABK Biomedical, which is developing a transformative Eye90 microspheres® technology, with the potential to provide in-procedure prognostic dosimetry for cutting-edge treatment of liver tumours – has partnered with the Canadian Nuclear Isotope Council. The CNIC is an independent body made up of representatives from the Canadian health sector, nuclear industry and leading research ...
SAN CARLOS, Calif., Jan. 14, 2020 /PRNewswire/ -- ZAP Surgical Systems, Inc. today announced that its ZAP-X® Gyroscopic Radiosurgery™ platform began clinical stereotactic radiosurgery (SRS) treatments at PLA General Hospital 301 (PLAGH 301) in Beijing, China. PLAGH 301 is the largest hospital in China with more than 20,000 outpatient treatments per day. For select indications ...
Jerry Simmons, CEO of MIFTEC, stated “Neutron flux of 1012is required to make radioisotopes in commercial quantities, and the exciting achievement of 1010by MIFTEC at the University of Nevada, Reno National Terawatt facility, tells us that our scientific predictions and device will work as designed. ...
CleanMed 2017 is an environmental sustainability conference for the healthcare sector and Haas Group International brought their product Maxcom to the expo in Minneapolis, MN to gain recognition within the healthcare industry. The healthcare attendees at CleanMed were very impressed with Maxcom and the capabilities and solutions that it offers for chemical challenges that are faced within the ...
ByIncora
Our facilities have been used in the past to produce radioisotopes for medicinal uses and this technology is a natural extension of our capabilities into new markets. ...